Apollo Hospitals to acquire 31% stake in Apollo Health for ₹1,254 crore

Apollo also announced on Friday its plans to set up a 100-bed Comprehensive Oncology Centre at Gurugram
| Photo Credit:
MOORTHY M

The Board of Apollo Hospitals on Friday approved the execution of a share purchase agreements to acquire 30.58 per cent equity stake held jointly by the International Finance Corporation, Washington (IFC) and IFC EAF in its subsidiary, Apollo Health and Lifestyle Ltd (AHLL). The total purchase consideration comes to ₹1,254 crore.

The transaction is subject to Competition Commission of India approvals. It is expected to be closed by November 2025 end. Upon completion of the proposed acquisition, AHLL will become a 99.4 per cent subsidiary of Apollo Hospitals, with balance held under ESOP pool, an exchange filing said.

AHLL’s principal activities include operation of speciality hospitals, clinics, diagnostic centres, sugar clinics, dental clinics and dialysis centres. The turnover of AHLL for FY25 was ₹1,553 crore on a consolidated basis.

Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise Ltd, said: “With disciplined growth, improved profitability and enhanced return on capital employed (ROCE), we see AHLL becoming a value-accretive driver in Apollo’s integrated healthcare portfolio.”

Sangita Reddy, Joint Managing Director, Apollo Hospitals Enterprise Ltd, said: “By bringing AHLL fully into Apollo’s fold, we are sharpening the business focus across its four verticals-primary care and diagnostics, birthing and women’s health, ambulatory care, and dialysis and dental.”

Oncology Centre

Apollo also announced on Friday its plans to set up a 100-bed Comprehensive Oncology Centre at Gurugram, integrating its advanced next-generation Proton Therapy System at an investment of ₹573 crore. The centre will be set up as part of the Phase 2 expansion of its upcoming 500-bed hospital in Gurugram. Phase 1 at Gurugram is to be commissioned by the end Q4 FY25 / Q1 FY26, while the Proton & Integrated Cancer Centre will follow, with completion targeted over the next four years.

This will be Apollo’s third Proton Therapy installation in India after Chennai and Hyderabad.

Published on September 12, 2025